These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16523315)

  • 1. [Pharmacotherapy of diabetes mellitus type 2. From the glucocentric tradition towards cardiovascular risk management].
    Jacob S; Marx N
    Internist (Berl); 2006 Apr; 47(4):434, 436-40. PubMed ID: 16523315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk reduction in the management of diabetic patients: what has changed since the '90s in the clinical approach?].
    Consoli A; Di Fulvio P
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):21S-26S. PubMed ID: 25623547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy].
    Hanefeld M; Metzler W; Köhler C; Schaper F
    Herz; 2006 May; 31(3):246-54; quiz 255. PubMed ID: 16770562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of rehabilitation with cardiovascular diabetic patients after surgical interventions].
    Jacob S
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i103-9. PubMed ID: 16598536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines.
    Mooradian AD
    Arch Intern Med; 2003 Jan; 163(1):33-40. PubMed ID: 12523914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
    Avogaro A
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the most effective approach to the reduction of cardiovascular risk in type-2 diabetes mellitus?].
    Simon K; Dobó E; Nádasy T; Retih I; Rácz I
    Orv Hetil; 2006 Aug; 147(31):1443-6. PubMed ID: 16981416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus: a cardiovascular disease.
    Candido R; Srivastava P; Cooper ME; Burrell LM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones.
    Greenberg AS
    J Diabetes Complications; 2003; 17(4):218-28. PubMed ID: 12810246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever.
    Basile JN
    Hosp Pract (1995); 2016; 44(1):9-20. PubMed ID: 26781810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertension in diabetic patients: outstanding issues.
    Camafort-Babkowski M; Barrios V; Coca A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):721-8. PubMed ID: 21714603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugar and fat, a recipe for disaster. New guidelines for the pharmacological management of diabetic dyslipidaemia.
    Tallis GA; Beng C; Popplewell P; Phillips P
    Aust Fam Physician; 1995 Sep; 24(9):1638-9, 1642-7, 1649. PubMed ID: 7487649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dyslipidemia, diabetes and cardiovascular disease].
    Hansen CN; Jensen TJ; Borch-Johnsen K
    Ugeskr Laeger; 2000 Aug; 162(33):4367-70. PubMed ID: 10962957
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Thrasher J
    Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.